Alzheimer’s illness (AD) is without doubt one of the most prevalent and clinically difficult neurodegenerative problems worldwide [1]. In 2024, it impacts practically 7 million People aged 65 and older, and as populations proceed to age, U.S. care prices are anticipated to exceed $1 trillion yearly by 2050 [2]. Globally, AD circumstances are projected to rise to 78 million by 2030 and 153 million by 2050, putting an immense socioeconomic and healthcare burden on societies [3]. Though the exact etiology of AD stays elusive, intensive proof implicates amyloid-β (Aβ) misfolding, tau hyperphosphorylation, and their irregular aggregation as key drivers of neuronal damage and demise, finally resulting in irreversible cognitive decline [4]. As a progressive and presently incurable situation, current therapeutic methods for AD are restricted to symptomatic reduction and modest delays in illness development [5]. Nevertheless, rising proof signifies that neuronal and synaptic dysfunction in the course of the earliest phases of AD precedes irreversible neurodegeneration and should stay partially reversible [6]. On this context, figuring out people in danger and intervening throughout this crucial window might considerably sluggish illness development, enhance affected person outcomes, and cut back the overwhelming burden on households and healthcare methods [7]. However, early-stage AD typically stays clinically silent; by the point sufferers exhibit noticeable signs, the optimum intervention window has normally closed, rendering well timed therapy exceedingly difficult [8]. To deal with this, creating extra accessible and scalable instruments for early AD prognosis and screening has change into a central objective in each scientific follow and analysis.
Presently, quite a few early diagnostic strategies for AD have been developed, primarily together with genetic testing [9], cognitive and neuropsychological evaluation [10], neuroimaging strategies [11], and physique fluid biomarker evaluation [12]. Genetic testing is especially efficient for detecting familial AD circumstances, nevertheless it gives restricted predictive worth for sporadic AD, which constitutes the overwhelming majority of circumstances. Cognitive assessments are non-invasive and cost-effective, but they sometimes lack enough sensitivity to detect impairments on the preclinical stage. Neuroimaging strategies, together with magnetic resonance imaging (MRI) and positron emission tomography (PET), present high-resolution insights into structural and useful mind adjustments, although they’re typically costly and out there solely at specialised medical facilities. Physique fluid biomarker evaluation, such because the measurement of Aβ and tau proteins in cerebrospinal fluid (CSF), can present direct proof of pathological adjustments however sometimes requires lumbar puncture (spinal faucet). Collectively, these approaches present complementary data, however their use for broad screening stays restricted by price, accessibility, procedural complexity, and, in some settings, suboptimal accuracy. Level-of-care testing (POCT) applied sciences have not too long ago gained consideration as a promising method to addressing this hole [13]. By enabling decentralized, well timed, and accessible biomarker evaluation with out reliance on specialised laboratory infrastructure, POCT gives a possible and scalable resolution to develop diagnostic attain and assist large-scale screening efforts. Due to this fact, there may be an pressing want for diagnostic instruments which might be correct, fast, cost-effective, scalable, and user-friendly, in addition to for transportable or home-testing units that allow early AD detection and population-level screening, together with amongst older adults and amongst middle-aged adults over 30 years outdated.
On this evaluate, we define the present understanding of AD pathogenesis and development and summarize current scientific approaches for early AD detection, highlighting their respective strengths and limitations. The core focus of this evaluate is to systematically study current advances in POCT applied sciences for early prognosis and large-scale inhabitants screening (Fig. 1). We categorize and examine consultant POCT platforms with respect to their sensing mechanisms, analytical efficiency, and translational potential. Lastly, we discover future instructions in POCT growth and current our views on potential methods to beat current obstacles and improve its scientific applicability for early AD prognosis. The event of POCT applied sciences for AD has the potential to make a significant scientific affect on the getting old inhabitants and to learn public well being and healthcare methods.
